Spanish Court Upholds Lipitor Patent

Law360, New York (July 25, 2007, 12:00 AM EDT) -- A Spanish court has handed drug maker Pfizer Inc. a partial victory in its ongoing battle against a generic version of blockbuster cholesterol drug Lipitor, upholding one patent for the main ingredient in the drug and invalidating another.

The Commercial Court of First Instance in Barcelona ruled on Tuesday that a generic version of Lipitor manufactured by Indian pharmaceutical company Ranbaxy Laboratories Ltd. would violate Pfizer's patent for atorvastatin, the active ingredient in the drug. But the court also found that a second patent, covering a...
To view the full article, register now.